熱點掃描 | 菸草概念上揚，思摩爾國際漲逾8%
uSMART盈立智投5月11日消息，截止發稿，港股三大指數漲跌互現，恆生指數上漲1.1%，報19854.33點，成交額565.63億；國企指數上漲1.67%，報6771.81點，成交額205.45億；紅籌指數下跌0.3%，報3729.68點，成交額19.87億。
醫美概念股漲幅居前，復星醫藥漲超14%，時代天使漲超5%，四環醫藥漲7%，三生製藥、復銳醫療科技漲逾6%；
菸草概念上揚，思摩爾國際漲逾8%，中國波頓漲超7%，比亞迪電子漲6.55%，華寶國際、中煙香港跟漲；
醫藥外包概念普漲，藥明生物漲超9%，昭衍新藥、金斯瑞生物科技漲逾8%，藥明康德、泰格醫藥、康龍化成、維亞生物漲超5%；
汽車股走強，理想汽車漲11%領漲，長城汽車漲近7%，比亞迪股份、吉利汽車漲逾6%，小鵬汽車、蔚來漲近6%；
熱門股
科濟藥業高開逾9%，現報11.44港元，漲幅13.04%，公司公告，公司的產品CT041的研究者發起試驗的期中分析結果在Nature Medicine上發表，該雜誌爲Nature旗下國際頂級醫學學術期刊。據悉，該結果題爲「Claudin18.2靶向CAR-T細胞在消化系統腫瘤中的I期期中分析試驗結果」，來自一項在中國開展的、多中心、開放標籤的I期臨牀試驗，研究CT041治療CLDN18.2表達陽性的晚期消化系統腫瘤患者的安全性、有效性和細胞代謝動力學；
同程旅行漲6.79%，現報13.84港元。公司昨日公佈，與山東能源集團國際酒店達成戰略合作，雙方將圍繞酒店管理、文旅康養、聯合餐飲三方面展開深入合作，促進山東文旅產業消費升級，深化文旅融合。同程集團聯合創始人、同程旅行CEO馬和平表示，在疫情反覆的特殊時刻，榮幸能與山能國際酒店合作，未來同程旅行將與山能通力合作，爲「十四五」山東文旅產業的高質量發展探索新機遇；
瑞聲科技漲2.76%，報17.12港元，瑞聲科技發佈公告，於2022年5月10日，賣方(爲誠瑞光學其中一名戰略投資者)訂立股份轉讓協議，內容有關將誠瑞光學已發行股份總數約0.5488%、0.1098%、0.1646%及0.7133%分別轉讓予常州新北、常州常高新、南寧廣投及瑞聲香港。完成後，賣方將依然爲誠瑞光學的戰略投資者，持有誠瑞光學已發行股份總數約0.5488%。董事認爲，引入新的誠瑞光學股東，將擴大股東基礎，並進一步增強戰略投資者的協同效應等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
